메뉴 건너뛰기




Volumn 6, Issue 1, 2014, Pages 24-33

Subviral particle as vaccine and vaccine platform

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INACTIVATED VACCINE; LIVE VACCINE; SUBUNIT VACCINE; VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

EID: 84896981541     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2014.02.009     Document Type: Review
Times cited : (37)

References (133)
  • 2
    • 84886091627 scopus 로고    scopus 로고
    • Virus-like particle-based human vaccines: Quality assessment based on structural and functional properties
    • This review article summarizes the long journey of the three commercial subviral particle vaccines from bench to patients. The physical properties and structural features of the three VLP vaccines are analyzed. The authors also summarize how the crucial quality attributes of VLP-based human vaccines against diseases were assessed, controlled, and improved during bioprocessing through an array of structural and functional analyses
    • Zhao Q, Li S, Yu H, Xia N, Modis Y: Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol 2013, 31:654-663. This review article summarizes the long journey of the three commercial subviral particle vaccines from bench to patients. The physical properties and structural features of the three VLP vaccines are analyzed. The authors also summarize how the crucial quality attributes of VLP-based human vaccines against diseases were assessed, controlled, and improved during bioprocessing through an array of structural and functional analyses.
    • (2013) Trends Biotechnol , vol.31 , pp. 654-663
    • Zhao, Q.1    Li, S.2    Yu, H.3    Xia, N.4    Modis, Y.5
  • 3
    • 20144372894 scopus 로고    scopus 로고
    • A bacterially expressed particulate hepatitis E vaccine: Antigenicity, immunogenicity and protectivity on primates
    • DOI 10.1016/j.vaccine.2004.11.064
    • Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH et al.: A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23:2893-2901. (Pubitemid 40386491)
    • (2005) Vaccine , vol.23 , Issue.22 , pp. 2893-2901
    • Li, S.W.1    Zhang, J.2    Li, Y.M.3    Ou, S.H.4    Huang, G.Y.5    He, Z.Q.6    Ge, S.X.7    Xian, Y.L.8    Pang, S.Q.9    Ng, M.H.10    Xia, N.S.11
  • 4
    • 55249104282 scopus 로고    scopus 로고
    • Noroviral P particle: Structure, function and applications in virus-host interaction
    • Tan M, Fang P, Chachiyo T, Xia M, Huang P, Fang Z, Jiang W, Jiang X: Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
    • (2008) Virology , vol.382 , pp. 115-123
    • Tan, M.1    Fang, P.2    Chachiyo, T.3    Xia, M.4    Huang, P.5    Fang, Z.6    Jiang, W.7    Jiang, X.8
  • 5
    • 78751706360 scopus 로고    scopus 로고
    • Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles
    • Tan M, Fang PA, Xia M, Chachiyo T, Jiang W, Jiang X: Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 2011, 410:345-352.
    • (2011) Virology , vol.410 , pp. 345-352
    • Tan, M.1    Fang, P.A.2    Xia, M.3    Chachiyo, T.4    Jiang, W.5    Jiang, X.6
  • 6
    • 27644437147 scopus 로고    scopus 로고
    • The P domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors
    • DOI 10.1128/JVI.79.22.14017-14030.2005
    • Tan M, Jiang X: The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 2005, 79:14017-14030. (Pubitemid 41552700)
    • (2005) Journal of Virology , vol.79 , Issue.22 , pp. 14017-14030
    • Tan, M.1    Jiang, X.2
  • 7
    • 0033696899 scopus 로고    scopus 로고
    • Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
    • Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC: Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000, 5:557-567.
    • (2000) Mol Cell , vol.5 , pp. 557-567
    • Chen, X.S.1    Garcea, R.L.2    Goldberg, I.3    Casini, G.4    Harrison, S.C.5
  • 9
    • 78650633210 scopus 로고    scopus 로고
    • Norovirus P particle, a novel platform for vaccine development and antibody production
    • This is a typical study showing the pattern of how a subviral particle is developed into a vaccine platform for antigen display for novel vaccine development
    • Tan M, Huang P, Xia M, Fang PA, Zhong W, McNeal M, Wei C, Jiang W, Jiang X: Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 2011, 85:753-764. This is a typical study showing the pattern of how a subviral particle is developed into a vaccine platform for antigen display for novel vaccine development.
    • (2011) J Virol , vol.85 , pp. 753-764
    • Tan, M.1    Huang, P.2    Xia, M.3    Fang, P.A.4    Zhong, W.5    McNeal, M.6    Wei, C.7    Jiang, W.8    Jiang, X.9
  • 11
    • 77953028997 scopus 로고    scopus 로고
    • Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
    • Jagu S, Kwak K, Garcea RL, Roden RB: Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection. Vaccine 2010, 28:4478-4486.
    • (2010) Vaccine , vol.28 , pp. 4478-4486
    • Jagu, S.1    Kwak, K.2    Garcea, R.L.3    Roden, R.B.4
  • 14
    • 0021238117 scopus 로고
    • Human hepatitis B vaccine from recombinant yeast
    • McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR: Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180. (Pubitemid 14132908)
    • (1984) Nature , vol.307 , Issue.5947 , pp. 178-180
    • McAleer, W.J.1    Buynak, E.B.2    Maigetter, R.Z.3
  • 15
    • 0023217653 scopus 로고
    • Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine
    • Andre FE, Safary A: Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Postgrad Med J 1987, 63(Suppl 2):169-177.
    • (1987) Postgrad Med J , vol.63 , Issue.SUPPL. 2 , pp. 169-177
    • Andre, F.E.1    Safary, A.2
  • 16
    • 84865328748 scopus 로고    scopus 로고
    • First HEV vaccine approved
    • Proffitt A: First HEV vaccine approved. Nat Biotechnol 2012, 30:300.
    • (2012) Nat Biotechnol , vol.30 , pp. 300
    • Proffitt, A.1
  • 17
    • 84872034033 scopus 로고    scopus 로고
    • Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development
    • Wu PC, Lin WL, Wu CM, Chi JN, Chien MS, Huang C: Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol 2012, 95:1501-1507.
    • (2012) Appl Microbiol Biotechnol , vol.95 , pp. 1501-1507
    • Wu, P.C.1    Lin, W.L.2    Wu, C.M.3    Chi, J.N.4    Chien, M.S.5    Huang, C.6
  • 18
  • 19
    • 83155182848 scopus 로고    scopus 로고
    • Norovirus vaccine against experimental human Norwalk Virus illness
    • This paper reported the first phase II clinical trials of norovirus VLP vaccine and demonstrated for the first time that norovirus VLP vaccine protects vaccinees against norovirus infection and illness
    • Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C et al.: Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011, 365:2178-2187. This paper reported the first phase II clinical trials of norovirus VLP vaccine and demonstrated for the first time that norovirus VLP vaccine protects vaccinees against norovirus infection and illness.
    • (2011) N Engl J Med , vol.365 , pp. 2178-2187
    • Atmar, R.L.1    Bernstein, D.I.2    Harro, C.D.3    Al-Ibrahim, M.S.4    Chen, W.H.5    Ferreira, J.6    Estes, M.K.7    Graham, D.Y.8    Opekun, A.R.9    Richardson, C.10
  • 20
    • 0034885747 scopus 로고    scopus 로고
    • Perspectives of vaccination against hepatitis E
    • Safary A: Perspectives of vaccination against hepatitis E. Intervirology 2001, 44 :162-166.
    • (2001) Intervirology , vol.44 , pp. 162-166
    • Safary, A.1
  • 23
    • 74949121478 scopus 로고    scopus 로고
    • From the circumsporozoite protein to the RTS, S/AS candidate vaccine
    • This review article summarizes the development process of the first subviral particle based-malaria vaccine from bench to patients. This includes the rational selection of the circumsporozoite protein (CSP) as the target antigen, the genesis of the RTS,S/AS concept, and the salient results of phase 2 studies
    • Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A: From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin 2010, 6:90-96. This review article summarizes the development process of the first subviral particle based-malaria vaccine from bench to patients. This includes the rational selection of the circumsporozoite protein (CSP) as the target antigen, the genesis of the RTS,S/AS concept, and the salient results of phase 2 studies.
    • (2010) Hum Vaccin , vol.6 , pp. 90-96
    • Cohen, J.1    Nussenzweig, V.2    Nussenzweig, R.3    Vekemans, J.4    Leach, A.5
  • 24
    • 84871037616 scopus 로고    scopus 로고
    • A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
    • Rts SCTP, This paper reported the results of the latest phase III clinical trial of the first subviral particle based malaria vaccine, RTS,S/AS01. The vaccine provided modest protection against both clinical and severe malaria in young infants
    • Rts SCTP, Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S et al.: A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med 2012, 367:2284-2295. This paper reported the results of the latest phase III clinical trial of the first subviral particle based malaria vaccine, RTS,S/AS01. The vaccine provided modest protection against both clinical and severe malaria in young infants.
    • (2012) N Engl J Med , vol.367 , pp. 2284-2295
    • Agnandji, S.T.1    Lell, B.2    Fernandes, J.F.3    Abossolo, B.P.4    Methogo, B.G.5    Kabwende, A.L.6    Adegnika, A.A.7    Mordmuller, B.8    Issifou, S.9
  • 25
    • 0036892173 scopus 로고    scopus 로고
    • A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts
    • DOI 10.1128/IAI.70.12.6860-6870.2002
    • Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E: A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect Immun 2002, 70:6860-6870. (Pubitemid 35387919)
    • (2002) Infection and Immunity , vol.70 , Issue.12 , pp. 6860-6870
    • Birkett, A.1    Lyons, K.2    Schmidt, A.3    Boyd, D.4    Oliveira, G.A.5    Siddique, A.6    Nussenzweig, R.7    Calvo-Calle, J.M.8    Nardin, E.9
  • 27
    • 0032874490 scopus 로고    scopus 로고
    • A universal influenza A vaccine based on the extracellular domain of the M2 protein
    • DOI 10.1038/13484
    • Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5:1157-1163. (Pubitemid 29474420)
    • (1999) Nature Medicine , vol.5 , Issue.10 , pp. 1157-1163
    • Neirynck, S.1    Deroo, T.2    Saelens, X.3    Vanlandschoot, P.4    Jou, W.M.5    Fiers, W.6
  • 28
    • 59649090229 scopus 로고    scopus 로고
    • Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
    • Fu TM, Grimm KM, Citron MP, Freed DC, Fan J, Keller PM, Shiver JW, Liang X, Joyce JG: Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine 2009, 27:1440-1447.
    • (2009) Vaccine , vol.27 , pp. 1440-1447
    • Fu, T.M.1    Grimm, K.M.2    Citron, M.P.3    Freed, D.C.4    Fan, J.5    Keller, P.M.6    Shiver, J.W.7    Liang, X.8    Joyce, J.G.9
  • 29
    • 58149116926 scopus 로고    scopus 로고
    • Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
    • De Filette M, Martens W, Smet A, Schotsaert M, Birkett A, Londono-Arcila P, Fiers W, Saelens X: Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 2008, 26:6503-6507.
    • (2008) Vaccine , vol.26 , pp. 6503-6507
    • De Filette, M.1    Martens, W.2    Smet, A.3    Schotsaert, M.4    Birkett, A.5    Londono-Arcila, P.6    Fiers, W.7    Saelens, X.8
  • 30
    • 19444368726 scopus 로고    scopus 로고
    • Universal influenza A vaccine: Optimization of M2-based constructs
    • DOI 10.1016/j.virol.2005.04.004, PII S0042682205002114
    • De Filette M, Min Jou W, Birkett A, Lyons K, Schultz B, Tonkyro A, Resch S, Fiers W: Universal influenza A vaccine: optimization of M2-based constructs. Virology 2005, 337 :149-161. (Pubitemid 40725448)
    • (2005) Virology , vol.337 , Issue.1 , pp. 149-161
    • De Filette, M.1    Jou, W.M.2    Birkett, A.3    Lyons, K.4    Schultz, B.5    Tonkyro, A.6    Resch, S.7    Fiers, W.8
  • 31
    • 29544452649 scopus 로고    scopus 로고
    • The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection
    • DOI 10.1016/j.vaccine.2005.08.061, PII S0264410X05008789
    • De Filette M, Ramne A, Birkett A, Lycke N, Lowenadler B, Min Jou W, Saelens X, Fiers W: The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 2006, 24:544-551. (Pubitemid 43017819)
    • (2006) Vaccine , vol.24 , Issue.5 , pp. 544-551
    • De Filette, M.1    Ramne, A.2    Birkett, A.3    Lycke, N.4    Lowenadler, B.5    Min, J.W.6    Saelens, X.7    Fiers, W.8
  • 33
    • 65449185906 scopus 로고    scopus 로고
    • Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments
    • Schotsaert M, De Filette M, Fiers W, Saelens X: Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines 2009, 8:499-508.
    • (2009) Expert Rev Vaccines , vol.8 , pp. 499-508
    • Schotsaert, M.1    De Filette, M.2    Fiers, W.3    Saelens, X.4
  • 37
    • 84959735857 scopus 로고
    • A statewide assessment of the role of Norwalk virus in outbreaks of food-borne gastroenteritis
    • Kuritsky JN, Osterholm MT, Korlath JA, White KE, Kaplan JE: A statewide assessment of the role of Norwalk virus in outbreaks of food-borne gastroenteritis. J Infect Dis 1985, 151:568.
    • (1985) J Infect Dis , vol.151 , pp. 568
    • Kuritsky, J.N.1    Osterholm, M.T.2    Korlath, J.A.3    White, K.E.4    Kaplan, J.E.5
  • 38
    • 84876931013 scopus 로고    scopus 로고
    • Norovirus P particle efficiently elicits innate, humoral and cellular immunity
    • This study described the data that norovirus P particle efficiently elicits innate, humoral and cellular immunity as a typical example of how a subviral particle inducing various immune responses
    • Fang H, Tan M, Xia M, Wang L, Jiang X: Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS ONE 2013, 8:e63269. This study described the data that norovirus P particle efficiently elicits innate, humoral and cellular immunity as a typical example of how a subviral particle inducing various immune responses.
    • (2013) PLoS ONE , vol.8
    • Fang, H.1    Tan, M.2    Xia, M.3    Wang, L.4    Jiang, X.5
  • 39
    • 84857030465 scopus 로고    scopus 로고
    • Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry
    • Bereszczak JZ, Barbu IM, Tan M, Xia M, Jiang X, van Duijn E, Heck AJ: Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry. J Struct Biol 2012, 177:273-282.
    • (2012) J Struct Biol , vol.177 , pp. 273-282
    • Bereszczak, J.Z.1    Barbu, I.M.2    Tan, M.3    Xia, M.4    Jiang, X.5    Van Duijn, E.6    Heck, A.J.7
  • 41
  • 42
    • 84893582328 scopus 로고    scopus 로고
    • Risk of intussusception after monovalent rotavirus vaccination
    • This new study indicated a risk of intussusception after rotavirus vaccination, suggestion a need of consideration of balancing between risks and health benefits of rotavirus vaccines
    • Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A et al.: Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014. This new study indicated a risk of intussusception after rotavirus vaccination, suggestion a need of consideration of balancing between risks and health benefits of rotavirus vaccines.
    • (2014) N Engl J Med
    • Weintraub, E.S.1    Baggs, J.2    Duffy, J.3    Vellozzi, C.4    Belongia, E.A.5    Irving, S.6    Klein, N.P.7    Glanz, J.M.8    Jacobsen, S.J.9    Naleway, A.10
  • 43
    • 84893551373 scopus 로고    scopus 로고
    • Rotavirus vaccines - Balancing intussusception risks and health benefits
    • Glass RI, Parashar UD: Rotavirus vaccines - balancing intussusception risks and health benefits. N Engl J Med 2014.
    • (2014) N Engl J Med
    • Glass, R.I.1    Parashar, U.D.2
  • 45
    • 0035896012 scopus 로고    scopus 로고
    • Papillomavirus capsid protein expression in Escherichia coli: Purification and assembly of HPV11 and HPV16 L1
    • DOI 10.1006/jmbi.2000.4464
    • Chen XS, Casini G, Harrison SC, Garcea RL: Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J Mol Biol 2001, 307:173-182. (Pubitemid 33029974)
    • (2001) Journal of Molecular Biology , vol.307 , Issue.1 , pp. 173-182
    • Chen, X.S.1    Casini, G.2    Harrison, S.C.3    Garcea, R.L.4
  • 46
    • 84878576654 scopus 로고    scopus 로고
    • Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus
    • Nam HM, Chae KS, Song YJ, Lee NH, Lee JB, Park SY, Song CS, Seo KH, Kang SM, Kim MC et al.: Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch Virol 2013, 158:1275-1285.
    • (2013) Arch Virol , vol.158 , pp. 1275-1285
    • Nam, H.M.1    Chae, K.S.2    Song, Y.J.3    Lee, N.H.4    Lee, J.B.5    Park, S.Y.6    Song, C.S.7    Seo, K.H.8    Kang, S.M.9    Kim, M.C.10
  • 47
    • 0037449062 scopus 로고    scopus 로고
    • Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines
    • DOI 10.1016/S0264-410X(02)00804-6
    • Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI: Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 2003, 21:3342-3350. (Pubitemid 36700433)
    • (2003) Vaccine , vol.21 , Issue.23 , pp. 3342-3350
    • Martinez-Torrecuadrada, J.L.1    Saubi, N.2    Pages-Mante, A.3    Caston, J.R.4    Espuna, E.5    Casal, J.I.6
  • 48
    • 0037449062 scopus 로고    scopus 로고
    • Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines
    • DOI 10.1016/S0264-410X(02)00822-8
    • Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, Casal JI: Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 2003, 21:1952-1960. (Pubitemid 36432102)
    • (2003) Vaccine , vol.21 , Issue.17-18 , pp. 1952-1960
    • Martinez-Torrecuadrada, J.L.1    Saubi, N.2    Pages-Mante, A.3    Caston, J.R.4    Espuna, E.5    Casal, J.I.6
  • 49
    • 84866042726 scopus 로고    scopus 로고
    • Virus-like particle-based countermeasures against Rift Valley fever virus
    • Koukuntla R, Mandell RB, Flick R: Virus-like particle-based countermeasures against Rift Valley fever virus. Zoonoses Public Health 2012, 59(Suppl 2):142-150.
    • (2012) Zoonoses Public Health , vol.59 , Issue.SUPPL. 2 , pp. 142-150
    • Koukuntla, R.1    Mandell, R.B.2    Flick, R.3
  • 50
    • 0029057747 scopus 로고
    • Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein
    • Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK: Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol 1995, 33:1452-1455.
    • (1995) J Clin Microbiol , vol.33 , pp. 1452-1455
    • Jiang, X.1    Matson, D.O.2    Ruiz-Palacios, G.M.3    Hu, J.4    Treanor, J.5    Pickering, L.K.6
  • 52
    • 0028122560 scopus 로고
    • Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection
    • Laurent S, Vautherot JF, Madelaine MF, Le Gall G, Rasschaert D: Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol 1994, 68:6794-6798. (Pubitemid 24294936)
    • (1994) Journal of Virology , vol.68 , Issue.10 , pp. 6794-6798
    • Laurent, S.1    Vautherot, J.-F.2    Madelaine, M.-F.3    Le, G.G.4    Rasschaert, D.5
  • 54
    • 4944266692 scopus 로고    scopus 로고
    • Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
    • DOI 10.1016/j.febslet.2004.09.009, PII S0014579304011238
    • Mortola E, Roy P: Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett 2004, 576:174-178. (Pubitemid 39330479)
    • (2004) FEBS Letters , vol.576 , Issue.1-2 , pp. 174-178
    • Mortola, E.1    Roy, P.2
  • 55
    • 49949116379 scopus 로고    scopus 로고
    • Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells
    • Bai B, Hu Q, Hu H, Zhou P, Shi Z, Meng J, Lu B, Huang Y, Mao P, Wang H: Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells. PLoS ONE 2008, 3:e2685.
    • (2008) PLoS ONE , vol.3
    • Bai, B.1    Hu, Q.2    Hu, H.3    Zhou, P.4    Shi, Z.5    Meng, J.6    Lu, B.7    Huang, Y.8    Mao, P.9    Wang, H.10
  • 56
    • 84886780209 scopus 로고    scopus 로고
    • Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins
    • Liu G, Lv L, Yin L, Li X, Luo D, Liu K, Xue C, Cao Y: Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins. Vaccine 2013, 31:5524-5530.
    • (2013) Vaccine , vol.31 , pp. 5524-5530
    • Liu, G.1    Lv, L.2    Yin, L.3    Li, X.4    Luo, D.5    Liu, K.6    Xue, C.7    Cao, Y.8
  • 57
    • 16244413211 scopus 로고    scopus 로고
    • Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
    • DOI 10.1016/j.vaccine.2004.11.070
    • Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S: Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 2005, 23:3033-3042. (Pubitemid 40462443)
    • (2005) Vaccine , vol.23 , Issue.23 , pp. 3033-3042
    • Swenson, D.L.1    Warfield, K.L.2    Negley, D.L.3    Schmaljohn, A.4    Aman, M.J.5    Bavari, S.6
  • 59
    • 0031977996 scopus 로고    scopus 로고
    • Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
    • Baumert TF, Ito S, Wong DT, Liang TJ: Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 1998, 72:3827-3836. (Pubitemid 28188682)
    • (1998) Journal of Virology , vol.72 , Issue.5 , pp. 3827-3836
    • Baumert, T.F.1    Ito, S.2    Wong, D.T.3    Liang, T.J.4
  • 60
    • 2942643933 scopus 로고    scopus 로고
    • Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates
    • DOI 10.1128/JVI.78.13.6995-7003.2004
    • Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ: Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J Virol 2004, 78:6995-7003. (Pubitemid 38781538)
    • (2004) Journal of Virology , vol.78 , Issue.13 , pp. 6995-7003
    • Jeong, S.-H.1    Qiao, M.2    Nascimbeni, M.3    Hu, Z.4    Rehermann, B.5    Murthy, K.6    Liang, T.J.7
  • 62
    • 84878804020 scopus 로고    scopus 로고
    • Prospects for prophylactic hepatitis C vaccines based on virus-like particles
    • Beaumont E, Roingeard P: Prospects for prophylactic hepatitis C vaccines based on virus-like particles. Hum Vaccin Immunother 2013, 9:1112-1118.
    • (2013) Hum Vaccin Immunother , vol.9 , pp. 1112-1118
    • Beaumont, E.1    Roingeard, P.2
  • 64
    • 14744292190 scopus 로고    scopus 로고
    • A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula
    • DOI 10.1002/eji.200425449
    • Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM: A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 2005, 35:655-665. (Pubitemid 40331342)
    • (2005) European Journal of Immunology , vol.35 , Issue.2 , pp. 655-665
    • Nassal, M.1    Skamel, C.2    Kratz, P.A.3    Wallich, R.4    Stehle, T.5    Simon, M.M.6
  • 65
    • 84896908376 scopus 로고    scopus 로고
    • Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate Lyme disease vaccines
    • Nassal M, Skamel C, Vogel M, Kratz PA, Stehle T, Wallich R, Simon MM: Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines. Int J Med Microbiol 2007.
    • (2007) Int J Med Microbiol
    • Nassal, M.1    Skamel, C.2    Vogel, M.3    Kratz, P.A.4    Stehle, T.5    Wallich, R.6    Simon, M.M.7
  • 66
    • 26444507185 scopus 로고    scopus 로고
    • Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus
    • DOI 10.1128/JVI.79.20.12999-13006.2005
    • Li TC, Takeda N, Miyamura T, Matsuura Y, Wang JC, Engvall H, Hammar L, Xing L, Cheng RH: Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol 2005, 79:12999-13006. (Pubitemid 41433219)
    • (2005) Journal of Virology , vol.79 , Issue.20 , pp. 12999-13006
    • Li, T.-C.1    Takeda, N.2    Miyamura, T.3    Matsuura, Y.4    Wang, J.C.Y.5    Engvall, H.6    Hammar, L.7    Xing, L.8    Cheng, R.H.9
  • 68
    • 77956618583 scopus 로고    scopus 로고
    • Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A largescale, randomised, double-blind placebo-controlled, phase 3 trial
    • Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP et al.: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a largescale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.
    • (2010) Lancet , vol.376 , pp. 895-902
    • Zhu, F.C.1    Zhang, J.2    Zhang, X.F.3    Zhou, C.4    Wang, Z.Z.5    Huang, S.J.6    Wang, H.7    Yang, C.L.8    Jiang, H.M.9    Cai, J.P.10
  • 70
    • 33749455623 scopus 로고    scopus 로고
    • Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles
    • DOI 10.1128/JVI.01098-06
    • Thiery R, Cozien J, Cabon J, Lamour F, Baud M, Schneemann A: Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles. J Virol 2006, 80:10201-10207. (Pubitemid 44522613)
    • (2006) Journal of Virology , vol.80 , Issue.20 , pp. 10201-10207
    • Thiery, R.1    Cozien, J.2    Cabon, J.3    Lamour, F.4    Baud, M.5    Schneemann, A.6
  • 71
    • 0036115177 scopus 로고    scopus 로고
    • Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses
    • DOI 10.1128/JVI.76.12.6370-6375.2002
    • Tang L, Lin CS, Krishna NK, Yeager M, Schneemann A, Johnson JE: Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses. J Virol 2002, 76:6370-6375. (Pubitemid 34556332)
    • (2002) Journal of Virology , vol.76 , Issue.12 , pp. 6370-6375
    • Tang, L.1    Lin, C.-S.2    Krishna, N.K.3    Yeager, M.4    Schneemann, A.5    Johnson, J.E.6
  • 74
    • 66149101000 scopus 로고    scopus 로고
    • Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge
    • Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM: Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009, 83:5726-5734.
    • (2009) J Virol , vol.83 , pp. 5726-5734
    • Perrone, L.A.1    Ahmad, A.2    Veguilla, V.3    Lu, X.4    Smith, G.5    Katz, J.M.6    Pushko, P.7    Tumpey, T.M.8
  • 75
    • 79960728140 scopus 로고    scopus 로고
    • Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes
    • Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM: Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 2011, 29:5911-5918.
    • (2011) Vaccine , vol.29 , pp. 5911-5918
    • Pushko, P.1    Pearce, M.B.2    Ahmad, A.3    Tretyakova, I.4    Smith, G.5    Belser, J.A.6    Tumpey, T.M.7
  • 77
    • 80052406550 scopus 로고    scopus 로고
    • Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice
    • Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW: Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis 2011, 204 :987-995.
    • (2011) J Infect Dis , vol.204 , pp. 987-995
    • Quan, F.S.1    Kim, Y.2    Lee, S.3    Yi, H.4    Kang, S.M.5    Bozja, J.6    Moore, M.L.7    Compans, R.W.8
  • 79
    • 0026531008 scopus 로고
    • Canine parvovirus empty capsids produced by expression in a baculovirus vector: Use in analysis of viral properties and immunization of dogs
    • Saliki JT, Mizak B, Flore HP, Gettig RR, Burand JP, Carmichael LE, Wood HA, Parrish CR: Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol 1992, 73(Pt 2):369-374.
    • (1992) J Gen Virol , vol.73 , Issue.PART 2 , pp. 369-374
    • Saliki, J.T.1    Mizak, B.2    Flore, H.P.3    Gettig, R.R.4    Burand, J.P.5    Carmichael, L.E.6    Wood, H.A.7    Parrish, C.R.8
  • 81
    • 84898897838 scopus 로고    scopus 로고
    • Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine
    • Xu J, Guo HC, Wei YQ, Dong H, Han SC, Ao D, Sun DH, Wang HM, Cao SZ, Sun SQ: Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine. Appl Microbiol Biotechnol 2014.
    • (2014) Appl Microbiol Biotechnol
    • Xu, J.1    Guo, H.C.2    Wei, Y.Q.3    Dong, H.4    Han, S.C.5    Ao, D.6    Sun, D.H.7    Wang, H.M.8    Cao, S.Z.9    Sun, S.Q.10
  • 82
    • 79956200555 scopus 로고    scopus 로고
    • Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose
    • Ju H, Wei N, Wang Q, Wang C, Jing Z, Guo L, Liu D, Gao M, Ma B, Wang J: Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose. Biochem Biophys Res Commun 2011, 409:131-136.
    • (2011) Biochem Biophys Res Commun , vol.409 , pp. 131-136
    • Ju, H.1    Wei, N.2    Wang, Q.3    Wang, C.4    Jing, Z.5    Guo, L.6    Liu, D.7    Gao, M.8    Ma, B.9    Wang, J.10
  • 85
    • 0031780717 scopus 로고    scopus 로고
    • Human papillomavirus type 11 recombinant L1 capsomeres induce virus- neutralizing antibodies
    • Rose RC, White WI, Li M, Suzich JA, Lane C, Garcea RL: Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies. J Virol 1998, 72:6151-6154. (Pubitemid 28283406)
    • (1998) Journal of Virology , vol.72 , Issue.7 , pp. 6151-6154
    • Rose, R.C.1    White, W.I.2    Li, M.3    Suzich, J.A.4    Lane, C.5    Garcea, R.L.6
  • 86
    • 0034872411 scopus 로고    scopus 로고
    • Immunization with a pentameric L1 fusion protein protects against papillomavirus infection
    • DOI 10.1128/JVI.75.17.7848-7853.2001
    • Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, Garcea RL, Schlegel R: Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol 2001, 75:7848-7853. (Pubitemid 32743655)
    • (2001) Journal of Virology , vol.75 , Issue.17 , pp. 7848-7853
    • Yuan, H.1    Eestes, P.A.2    Chen, Y.3    Newsome, J.4    Olcese, V.A.5    Garcea, R.L.6    Schlegel, R.7
  • 87
    • 79955121411 scopus 로고    scopus 로고
    • Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
    • Jeoung HY, Lee WH, Jeong W, Shin BH, Choi HW, Lee HS, An DJ: Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig. Virol J 2011, 8:170.
    • (2011) Virol J , vol.8 , pp. 170
    • Jeoung, H.Y.1    Lee, W.H.2    Jeong, W.3    Shin, B.H.4    Choi, H.W.5    Lee, H.S.6    An, D.J.7
  • 88
    • 84862809216 scopus 로고    scopus 로고
    • Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis
    • Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H: Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 2012, 30:2301-2308.
    • (2012) Vaccine , vol.30 , pp. 2301-2308
    • Zhang, L.1    Parham, N.J.2    Zhang, F.3    Aasa-Chapman, M.4    Gould, E.A.5    Zhang, H.6
  • 89
    • 84867482187 scopus 로고    scopus 로고
    • A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge
    • Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z: A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 2012, 30:6642-6648.
    • (2012) Vaccine , vol.30 , pp. 6642-6648
    • Liu, Q.1    Yan, K.2    Feng, Y.3    Huang, X.4    Ku, Z.5    Cai, Y.6    Liu, F.7    Shi, J.8    Huang, Z.9
  • 90
    • 40849137446 scopus 로고    scopus 로고
    • Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge
    • Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC: Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
    • (2008) Vaccine , vol.26 , pp. 1855-1862
    • Chung, Y.C.1    Ho, M.S.2    Wu, J.C.3    Chen, W.J.4    Huang, J.H.5    Chou, S.T.6    Hu, Y.C.7
  • 91
    • 84862786637 scopus 로고    scopus 로고
    • Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles
    • Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL: Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 2012, 30:1305-1312.
    • (2012) Vaccine , vol.30 , pp. 1305-1312
    • Lin, Y.L.1    Yu, C.I.2    Hu, Y.C.3    Tsai, T.J.4    Kuo, Y.C.5    Chi, W.K.6    Lin, A.N.7    Chiang, B.L.8
  • 92
    • 84879460493 scopus 로고    scopus 로고
    • Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
    • Li HY, Han JF, Qin CF, Chen R: Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 2013, 31:3281-3287.
    • (2013) Vaccine , vol.31 , pp. 3281-3287
    • Li, H.Y.1    Han, J.F.2    Qin, C.F.3    Chen, R.4
  • 94
    • 84879815475 scopus 로고    scopus 로고
    • Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle
    • Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, Sun DH, Yin SH, Ma JW, Liu ZX, Guo JH et al.: Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet Res 2013, 44 :48.
    • (2013) Vet Res , vol.44 , pp. 48
    • Guo, H.C.1    Sun, S.Q.2    Jin, Y.3    Yang, S.L.4    Wei, Y.Q.5    Sun, D.H.6    Yin, S.H.7    Ma, J.W.8    Liu, Z.X.9    Guo, J.H.10
  • 95
    • 0342323856 scopus 로고    scopus 로고
    • Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein
    • DOI 10.1006/viro.2000.0392
    • Gedvilaite A, Frommel C, Sasnauskas K, Micheel B, Ozel M, Behrsing O, Staniulis J, Jandrig B, Scherneck S, Ulrich R: Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 2000, 273:21-35. (Pubitemid 30602004)
    • (2000) Virology , vol.273 , Issue.1 , pp. 21-35
    • Gedvilaite, A.1    Frommel, C.2    Sasnauskas, K.3    Micheel, B.4    Ozel, M.5    Behrsing, O.6    Staniulis, J.7    Jandrig, B.8    Scherneck, S.9    Ulrich, R.10
  • 96
    • 1542513302 scopus 로고    scopus 로고
    • Segments of Puumala Hantavirus Nucleocapsid Protein Inserted into Chimeric Polyomavirus-Derived Virus-Like Particles Induce a Strong Immune Response in Mice
    • DOI 10.1089/088282404322875458
    • Gedvilaite A, Zvirbliene A, Staniulis J, Sasnauskas K, Kruger DH, Ulrich R: Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol 2004, 17:51-68. (Pubitemid 38338462)
    • (2004) Viral Immunology , vol.17 , Issue.1 , pp. 51-68
    • Gedvilaite, A.1    Zvirbliene, A.2    Staniulis, J.3    Sasnauskas, K.4    Kruger, D.H.5    Ulrich, R.6
  • 98
    • 84855584421 scopus 로고    scopus 로고
    • Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope
    • Mazeike E, Gedvilaite A, Blohm U: Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope. Virus Res 2012, 163:2-10.
    • (2012) Virus Res , vol.163 , pp. 2-10
    • Mazeike, E.1    Gedvilaite, A.2    Blohm, U.3
  • 100
    • 21344434789 scopus 로고    scopus 로고
    • A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors
    • DOI 10.1158/0008-5472.CAN-05-0335
    • Tegerstedt K, Lindencrona JA, Curcio C, Andreasson K, Tullus C, Forni G, Dalianis T, Kiessling R, Ramqvist T: A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors. Cancer Res 2005, 65:5953-5957. (Pubitemid 40911202)
    • (2005) Cancer Research , vol.65 , Issue.13 , pp. 5953-5957
    • Tegerstedt, K.1    Lindencrona, J.A.2    Curcio, C.3    Andreasson, K.4    Tullus, C.5    Forni, G.6    Dalianis, T.7    Kiessling, R.8    Ramqvist, T.9
  • 101
    • 80051766150 scopus 로고    scopus 로고
    • Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor
    • Eriksson M, Andreasson K, Weidmann J, Lundberg K, Tegerstedt K, Dalianis T, Ramqvist T: Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor. PLoS ONE 2011, 6:e23828.
    • (2011) PLoS ONE , vol.6
    • Eriksson, M.1    Andreasson, K.2    Weidmann, J.3    Lundberg, K.4    Tegerstedt, K.5    Dalianis, T.6    Ramqvist, T.7
  • 102
    • 39049183787 scopus 로고    scopus 로고
    • Development of a vaccine marker technology: Display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination
    • Neugebauer M, Walders B, Brinkman M, Ruehland C, Schumacher T, Bertling WM, Geuther E, Reiser CO, Reichel C, Strich S et al.: Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination. Biotechnol J 2006, 1:1435-1446.
    • (2006) Biotechnol J , vol.1 , pp. 1435-1446
    • Neugebauer, M.1    Walders, B.2    Brinkman, M.3    Ruehland, C.4    Schumacher, T.5    Bertling, W.M.6    Geuther, E.7    Reiser, C.O.8    Reichel, C.9    Strich, S.10
  • 103
    • 84874082507 scopus 로고    scopus 로고
    • SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier
    • Kawano M, Matsui M, Handa H: SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier. Expert Rev Vaccines 2013, 12:199-210.
    • (2013) Expert Rev Vaccines , vol.12 , pp. 199-210
    • Kawano, M.1    Matsui, M.2    Handa, H.3
  • 104
    • 79952804470 scopus 로고    scopus 로고
    • Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery
    • Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z: Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem 2011, 22:346-352.
    • (2011) Bioconjug Chem , vol.22 , pp. 346-352
    • Zhao, Q.1    Chen, W.2    Chen, Y.3    Zhang, L.4    Zhang, J.5    Zhang, Z.6
  • 105
    • 77955676002 scopus 로고    scopus 로고
    • VP6: A candidate rotavirus vaccine
    • Ward RL, McNeal MM: VP6: a candidate rotavirus vaccine. J Infect Dis 2010, 202(Suppl):S101-S107.
    • (2010) J Infect Dis , vol.202 , Issue.SUPPL.
    • Ward, R.L.1    McNeal, M.M.2
  • 106
    • 84874054717 scopus 로고    scopus 로고
    • Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease
    • Azevedo MP, Vlasova AN, Saif LJ: Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev Vaccines 2013, 12:169-181.
    • (2013) Expert Rev Vaccines , vol.12 , pp. 169-181
    • Azevedo, M.P.1    Vlasova, A.N.2    Saif, L.J.3
  • 107
    • 0026601133 scopus 로고
    • Protective efficacy of virus-like particles for bluetongue disease
    • Roy P, French T, Erasmus BJ: Protective efficacy of virus-like particles for bluetongue disease. Vaccine 1992, 10:28-32.
    • (1992) Vaccine , vol.10 , pp. 28-32
    • Roy, P.1    French, T.2    Erasmus, B.J.3
  • 108
    • 0025331991 scopus 로고
    • Recombinant virus vaccine for bluetongue disease in sheep
    • Roy P, Urakawa T, Van Dijk AA, Erasmus BJ: Recombinant virus vaccine for bluetongue disease in sheep. J Virol 1990, 64:1998-2003. (Pubitemid 20148441)
    • (1990) Journal of Virology , vol.64 , Issue.5 , pp. 1998-2003
    • Roy, P.1    Urakawa, T.2    Van Dijk, A.A.3    Erasmus, B.J.4
  • 109
    • 84871664118 scopus 로고    scopus 로고
    • Bluetongue virus serotype 8 viruslike particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen
    • Stewart M, Dubois E, Sailleau C, Breard E, Viarouge C, Desprat A, Thiery R, Zientara S, Roy P: Bluetongue virus serotype 8 viruslike particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine 2013, 31:553-558.
    • (2013) Vaccine , vol.31 , pp. 553-558
    • Stewart, M.1    Dubois, E.2    Sailleau, C.3    Breard, E.4    Viarouge, C.5    Desprat, A.6    Thiery, R.7    Zientara, S.8    Roy, P.9
  • 110
  • 112
    • 0029057169 scopus 로고
    • Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine
    • Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R, Heppner DG, Yuan G, Hollingdale M, Slaoui M et al.: Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis 1995, 171:1576-1585.
    • (1995) J Infect Dis , vol.171 , pp. 1576-1585
    • Gordon, D.M.1    McGovern, T.W.2    Krzych, U.3    Cohen, J.C.4    Schneider, I.5    LaChance, R.6    Heppner, D.G.7    Yuan, G.8    Hollingdale, M.9    Slaoui, M.10
  • 117
    • 0035858128 scopus 로고    scopus 로고
    • Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat
    • DOI 10.1016/S0264-410X(01)00080-9, PII S0264410X01000809
    • Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR, Flock JI: Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 2001, 19:3376-3383. (Pubitemid 32710286)
    • (2001) Vaccine , vol.19 , Issue.25-26 , pp. 3376-3383
    • Rennermalm, A.1    Li, Y.-H.2    Bohaufs, L.3    Jarstrand, C.4    Brauner, A.5    Brennan, F.R.6    Flock, J.-I.7
  • 118
    • 84896989856 scopus 로고    scopus 로고
    • Production and immunogenicity of chimeric virus-like particles (VLPs) containing the spike (S1) glycoprotein of infectious bronchitis virus (IBV)
    • Lv L, Li X, Liu G, Li R, Liu Q, Shen H, Wang W, Xue C, Cao Y: Production and immunogenicity of chimeric virus-like particles (VLPs) containing the spike (S1) glycoprotein of infectious bronchitis virus (IBV). J Vet Sci 2013.
    • (2013) J Vet Sci
    • Lv, L.1    Li, X.2    Liu, G.3    Li, R.4    Liu, Q.5    Shen, H.6    Wang, W.7    Xue, C.8    Cao, Y.9
  • 119
    • 84888206375 scopus 로고    scopus 로고
    • Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease
    • Shen H, Xue C, Lv L, Wang W, Liu Q, Liu K, Chen X, Zheng J, Li X, Cao Y: Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease. Virus Res 2013, 178:430-436.
    • (2013) Virus Res , vol.178 , pp. 430-436
    • Shen, H.1    Xue, C.2    Lv, L.3    Wang, W.4    Liu, Q.5    Liu, K.6    Chen, X.7    Zheng, J.8    Li, X.9    Cao, Y.10
  • 120
    • 84880686616 scopus 로고    scopus 로고
    • Construction, expression and immunogenicity of a novel antihypertension angiotensin II vaccine based on hepatitis A virus-like particle
    • Ou X, Guo L, Wu J, Mi K, Yin N, Zhang G, Li H, Sun M: Construction, expression and immunogenicity of a novel antihypertension angiotensin II vaccine based on hepatitis A virus-like particle. Hum Vaccin Immunother 2013, 9:1191-1199.
    • (2013) Hum Vaccin Immunother , vol.9 , pp. 1191-1199
    • Ou, X.1    Guo, L.2    Wu, J.3    Mi, K.4    Yin, N.5    Zhang, G.6    Li, H.7    Sun, M.8
  • 121
    • 84890876293 scopus 로고    scopus 로고
    • Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms
    • Ye X, Ku Z, Liu Q, Wang X, Shi J, Zhang Y, Kong L, Cong Y, Huang Z: Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol 2014, 88:72-81.
    • (2014) J Virol , vol.88 , pp. 72-81
    • Ye, X.1    Ku, Z.2    Liu, Q.3    Wang, X.4    Shi, J.5    Zhang, Y.6    Kong, L.7    Cong, Y.8    Huang, Z.9
  • 122
    • 77953148122 scopus 로고    scopus 로고
    • Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes
    • Sominskaya I, Skrastina D, Dislers A, Vasiljev D, Mihailova M, Ose V, Dreilina D, Pumpens P: Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes. Clin Vaccine Immunol 2010, 17:1027-1033.
    • (2010) Clin Vaccine Immunol , vol.17 , pp. 1027-1033
    • Sominskaya, I.1    Skrastina, D.2    Dislers, A.3    Vasiljev, D.4    Mihailova, M.5    Ose, V.6    Dreilina, D.7    Pumpens, P.8
  • 123
    • 34447276481 scopus 로고    scopus 로고
    • Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies
    • Vietheer PT, Boo I, Drummer HE, Netter HJ: Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Antivir Ther 2007, 12:477-487. (Pubitemid 47041146)
    • (2007) Antiviral Therapy , vol.12 , Issue.4 , pp. 477-487
    • Vietheer, P.T.K.1    Boo, I.2    Drummer, H.E.3    Netter, H.-J.4
  • 124
    • 84864607163 scopus 로고    scopus 로고
    • Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
    • Arora U, Tyagi P, Swaminathan S, Khanna N: Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. J Nanobiotechnol 2012, 10:30.
    • (2012) J Nanobiotechnol , vol.10 , pp. 30
    • Arora, U.1    Tyagi, P.2    Swaminathan, S.3    Khanna, N.4
  • 125
    • 84872610842 scopus 로고    scopus 로고
    • Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
    • Arora U, Tyagi P, Swaminathan S, Khanna N: Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 2013, 31:873-878.
    • (2013) Vaccine , vol.31 , pp. 873-878
    • Arora, U.1    Tyagi, P.2    Swaminathan, S.3    Khanna, N.4
  • 127
    • 84862813537 scopus 로고    scopus 로고
    • Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV
    • Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP: Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV. Vaccine 2012, 30:2125-2130.
    • (2012) Vaccine , vol.30 , pp. 2125-2130
    • Wang, Y.S.1    Ouyang, W.2    Liu, X.J.3    He, K.W.4    Yu, S.Q.5    Zhang, H.B.6    Fan, H.J.7    Lu, C.P.8
  • 128
    • 84874822639 scopus 로고    scopus 로고
    • Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles
    • Dhanasooraj D, Kumar RA, Mundayoor S: Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles. Int J Nanomed 2013, 8:835-843.
    • (2013) Int J Nanomed , vol.8 , pp. 835-843
    • Dhanasooraj, D.1    Kumar, R.A.2    Mundayoor, S.3
  • 129
    • 84876671666 scopus 로고    scopus 로고
    • A novel platform for virus-like particle-display of flaviviral envelope domain III: Induction of Dengue and West Nile virus neutralizing antibodies
    • Chua AJ, Vituret C, Tan ML, Gonzalez G, Boulanger P, Ng ML, Hong SS: A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies. Virol J 2013, 10:129.
    • (2013) Virol J , vol.10 , pp. 129
    • Chua, A.J.1    Vituret, C.2    Tan, M.L.3    Gonzalez, G.4    Boulanger, P.5    Ng, M.L.6    Hong, S.S.7
  • 131
  • 132
    • 84882844869 scopus 로고    scopus 로고
    • Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle
    • Anggraeni MR, Connors NK, Wu Y, Chuan YP, Lua LH, Middelberg AP: Sensitivity of immune response quality to influenza helix 190 antigen structure
    • (2013) Vaccine , vol.31 , pp. 4428-4435
    • Anggraeni, M.R.1    Connors, N.K.2    Wu, Y.3    Chuan, Y.P.4    Lua, L.H.5    Middelberg, A.P.6
  • 133
    • 84886411258 scopus 로고    scopus 로고
    • Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants
    • Kawano M, Morikawa K, Suda T, Ohno N, Matsushita S, Akatsuka T, Handa H, Matsui M: Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants. Virology 2014, 448:159-167.
    • (2014) Virology , vol.448 , pp. 159-167
    • Kawano, M.1    Morikawa, K.2    Suda, T.3    Ohno, N.4    Matsushita, S.5    Akatsuka, T.6    Handa, H.7    Matsui, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.